{
  "image_filename": "figure_p3_det_2_000.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/figure_p3_det_2_000.png",
  "image_type": "Figure",
  "page_number": 3,
  "block_id": "det_2_000",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "A CONSORT-style flow diagram showing 4,648 subjects enrolled and randomized to receive either FluBlok (n=2,344) or placebo (n=2,304), with details on discontinuations and resulting safety populations. does not support the claim because the pivotal trial comparator shown is placebo, not Fluarix (quadrivalent standard-dose vaccine). Note: No mention of Fluarix in the diagram; only placebo is used as the comparator.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A CONSORT-style flow diagram showing 4,648 subjects enrolled and randomized to receive either FluBlok (n=2,344) or placebo (n=2,304), with details on discontinuations and resulting safety populations.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the pivotal trial comparator shown is placebo, not Fluarix (quadrivalent standard-dose vaccine).",
    "confidence_notes": "No mention of Fluarix in the diagram; only placebo is used as the comparator."
  }
}